# Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer

> **NCT02254941** · — · UNKNOWN · sponsor: **Grupo Espanol Multidisciplinario del Cancer Digestivo** · enrollment: 1104 (actual)

## Conditions studied

- Metastatic Colon Cancer

## Interventions

- **DRUG:** Chemotherapy
- **BIOLOGICAL:** Chemotherapy plus monoclonal antibody

## Key facts

- **NCT ID:** NCT02254941
- **Lead sponsor:** Grupo Espanol Multidisciplinario del Cancer Digestivo
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-08
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 1104 (ACTUAL)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02254941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02254941, "Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02254941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*